1: Lee JH, Park YW, Park MH, Yoo TK. Safety and efficacy of tamsulosin 0.4 mg as an initial dose in 1,219 Korean patients with moderate to severe lower urinary tract symptoms: data from a phase IV study. Prostate Int. 2023 Dec;11(4):228-232. doi: 10.1016/j.prnil.2023.09.003. Epub 2023 Sep 21. PMID: 38196556; PMCID: PMC10772215.
2: Lee KS, Yoo TK, Liao L, Wang J, Chuang YC, Liu SP, Chu R, Sumarsono B. Association of lower urinary tract symptoms and OAB severity with quality of life and mental health in China, Taiwan and South Korea: results from a cross- sectional, population-based study. BMC Urol. 2017 Nov 21;17(1):108. doi: 10.1186/s12894-017-0294-3. PMID: 29162085; PMCID: PMC5698954.
3: Cho JM, Moon KT, Yoo TK. Robotic Simple Prostatectomy: Why and How? Int Neurourol J. 2020 Mar;24(1):12-20. doi: 10.5213/inj.2040018.009. Epub 2020 Mar 31. PMID: 32252182; PMCID: PMC7136446.
4: Kim DY, Ryu JH, Yoo TK, Kim YB, Jung TY, Ko WJ, Yang EK. Analysis of distress in patients undergoing radical prostatectomy: A multicenter prospective study. Investig Clin Urol. 2024 Jan;65(1):40-52. doi: 10.4111/icu.20230286. PMID: 38197750; PMCID: PMC10789535.
5: Cho JM, Sun S, Im E, Yang H, Yoo TK. Triple Silencing of HSP27, cFLIP, and CLU Genes Promotes the Sensitivity of Doxazosin-Induced Apoptosis in PC-3 Prostate Cancer Cells. Medicines (Basel). 2024 Feb 21;11(3):7. doi: 10.3390/medicines11030007. PMID: 38535120; PMCID: PMC10971947.
6: Cho JM, Lee SW, Kang JY, Yoo TK. Safety and efficacy of combined transrectal ultrasound-guided prostate needle biopsy and transurethral resection of the prostate. Korean J Urol. 2010 Feb;51(2):101-5. doi: 10.4111/kju.2010.51.2.101. Epub 2010 Feb 18. PMID: 20414421; PMCID: PMC2855484.
7: Lee SW, Cho JM, Cho HJ, Kang JY, Kim EK, Yoo TK. Expression levels of heat shock protein 27 and cellular FLICE-like inhibitory protein in prostate cancer correlate with Gleason score sum and pathologic stage. Korean J Urol. 2015 Jul;56(7):505-14. doi: 10.4111/kju.2015.56.7.505. Epub 2015 Jul 7. PMID: 26175869; PMCID: PMC4500807.
8: Yoo TK. Reconsidering molecular pathways in giant benign prostatic hyperplasia: a potential strategy for an unmet challenge. Expert Rev Clin Pharmacol. 2026 Jan-Feb;19(2):101-104. doi: 10.1080/17512433.2026.2632932. Epub 2026 Mar 1. PMID: 41693447.
9: Cho HJ, Shin SC, Cho JM, Kang JY, Yoo TK. The role of transurethral resection of the prostate for patients with an elevated prostate-specific antigen. Prostate Int. 2014 Dec;2(4):196-202. doi: 10.12954/PI.14060. Epub 2014 Dec 30. PMID: 25599076; PMCID: PMC4286732.
10: Kim W, Yoo TK, Kim SJ, Shin DJ, Tyler-Smith C, Jin HJ, Kwak KD, Kim ET, Bae YS. Lack of association between Y-chromosomal haplogroups and prostate cancer in the Korean population. PLoS One. 2007 Jan 24;2(1):e172. doi: 10.1371/journal.pone.0000172. PMID: 17245448; PMCID: PMC1766463.
11: Yoo TK, Cho HJ. Benign prostatic hyperplasia: from bench to clinic. Korean J Urol. 2012 Mar;53(3):139-48. doi: 10.4111/kju.2012.53.3.139. Epub 2012 Mar 19. PMID: 22468207; PMCID: PMC3312060.
12: Cho HJ, Yoo TK. Silodosin for the treatment of clinical benign prostatic hyperplasia: safety, efficacy, and patient acceptability. Res Rep Urol. 2014 Sep 26;6:113-9. doi: 10.2147/RRU.S41618. PMID: 25328864; PMCID: PMC4199653.
13: Youm YH, Yang H, Yoon YD, Kim DY, Lee C, Yoo TK. Doxazosin-induced clusterin expression and apoptosis in prostate cancer cells. Urol Oncol. 2007 Nov- Dec;25(6):483-8. doi: 10.1016/j.urolonc.2007.02.010. PMID: 18047956.
14: Seok E, Lee DM, Yang H, Yoo TK. Interleukin-6 secreted by tumor-associated macrophages promotes proliferation and migration through JAK2/STAT3 signaling pathway in human prostate cancer cells. Prostate Int. 2026 Mar;14(1):59-67. doi: 10.1016/j.prnil.2025.11.002. Epub 2025 Nov 17. PMID: 41908237; PMCID: PMC13030948.
15: Kim SS, Cho HJ, Cho JM, Kang JY, Yang HW, Yoo TK. Dual silencing of Hsp27 and c-FLIP enhances doxazosin-induced apoptosis in PC-3 prostate cancer cells. ScientificWorldJournal. 2013 Jun 19;2013:174392. doi: 10.1155/2013/174392. PMID: 23853530; PMCID: PMC3703906.
16: Shim JH, Danielpour D, Lee C, Kim YS, Bahk YY, Yoo TK. Proteome profile changes during transdifferentiation of NRP-152 rat prostatic basal epithelial cells. Mol Cells. 2004 Feb 29;17(1):108-16. PMID: 15055536.
17: Cho JM, Moon KT, Lee JH, Choi JD, Kang JY, Yoo TK. Open simple prostatectomy and robotic simple prostatectomy for large benign prostatic hyperplasia: Comparison of safety and efficacy. Prostate Int. 2021 Jun;9(2):101-106. doi: 10.1016/j.prnil.2020.11.004. Epub 2021 Jan 12. PMID: 34386453; PMCID: PMC8322925.
18: Moon KT, Yoo TK, Kwon SY, Ha JY, Byun SS, Kim JH, Chung JI, Kim TH, Moon HS, Kim SJ, Lee KS. A randomised, placebo-controlled, multicentre, Phase 2 clinical trial to evaluate the efficacy and safety of GV1001 in patients with benign prostatic hyperplasia. BJU Int. 2018 Aug;122(2):283-292. doi: 10.1111/bju.14233. Epub 2018 May 4. PMID: 29633507.
19: Yoo TK, Lee KS, Sumarsono B, Kim ST, Kim HJ, Lee HC, Kim SH. The prevalence of lower urinary tract symptoms in population aged 40 years or over, in South Korea. Investig Clin Urol. 2018 May;59(3):166-176. doi: 10.4111/icu.2018.59.3.166. Epub 2018 Apr 23. PMID: 29744473; PMCID: PMC5934278.
20: Ryu JH, Kim YB, Jung TY, Ko WJ, Kim SI, Kwon D, Kim DY, Oh TH, Yoo TK. Practice Patterns of Korean Urologists Regarding Positive Surgical Margins after Radical Prostatectomy: a Survey and Narrative Review. J Korean Med Sci. 2021 Oct 25;36(41):e256. doi: 10.3346/jkms.2021.36.e256. PMID: 34697927; PMCID: PMC8546307.
21: Kim W, Yoo TK, Shin DJ, Rho HW, Jin HJ, Kim ET, Bae YS. Mitochondrial DNA haplogroup analysis reveals no association between the common genetic lineages and prostate cancer in the Korean population. PLoS One. 2008 May 21;3(5):e2211. doi: 10.1371/journal.pone.0002211. PMID: 18493608; PMCID: PMC2376063.
22: Park A, Lee J, Mun S, Kim DJ, Cha BH, Moon KT, Yoo TK, Kang HG. Identification of Transcription Factor YY1 as a Regulator of a Prostate Cancer- Specific Pathway Using Proteomic Analysis. J Cancer. 2017 Jul 20;8(12):2303-2311. doi: 10.7150/jca.19036. PMID: 28819434; PMCID: PMC5560149.
23: Ryu JH, Kim SJ, Kim YB, Jung TY, Ko WJ, Kim SI, Kim DY, Oh TH, Moon KT, Cho HJ, Cho JM, Yoo TK. Radical prostatectomy for clinically localized prostate cancer in patients aged 75 years or older: comparison with primary androgen deprivation therapy. Aging Male. 2018 Mar;21(1):17-23. doi: 10.1080/13685538.2017.1365122. Epub 2017 Aug 22. PMID: 28828908.
24: Kim SS, Cho HJ, Kang JY, Kang HK, Yoo TK. Inhibition of androgen receptor expression with small interfering RNA enhances cancer cell apoptosis by suppressing survival factors in androgen insensitive, late stage LNCaP cells. ScientificWorldJournal. 2013;2013:519397. doi: 10.1155/2013/519397. Epub 2013 Feb 6. PMID: 23476140; PMCID: PMC3580912.
25: Min DS, Cho HJ, Kang JY, Yoo TK, Cho JM. Effect of transurethral resection of the prostate based on the degree of obstruction seen in urodynamic study. Korean J Urol. 2013 Dec;54(12):840-5. doi: 10.4111/kju.2013.54.12.840. Epub 2013 Dec 10. PMID: 24363865; PMCID: PMC3866287.
26: Seo DY, Cho HJ, Cho JM, Kang JY, Yoo TK. Experience with robot-assisted laparoscopic radical prostatectomy at a secondary training hospital: operation time, treatment outcomes, and complications with the accumulation of experience. Korean J Urol. 2013 Aug;54(8):522-6. doi: 10.4111/kju.2013.54.8.522. Epub 2013 Aug 7. PMID: 23956827; PMCID: PMC3742904.
27: Ryu JH, Kim YB, Jung TY, Kim SI, Byun SS, Kwon DD, Kim DY, Oh TH, Yoo TK, Ko WJ. Radical Prostatectomy in Korean Men Aged 75-Years or Older: Safety and Efficacy in Comparison with Patients Aged 65-69 Years. J Korean Med Sci. 2016 Jun;31(6):957-62. doi: 10.3346/jkms.2016.31.6.957. Epub 2016 Apr 25. PMID: 27247506; PMCID: PMC4853676.
28: Youm YH, Kim S, Bahk YY, Yoo TK. Proteomic analysis of androgen-independent growth in low and high passage human LNCaP prostatic adenocarcinoma cells. BMB Rep. 2008 Oct 31;41(10):722-7. doi: 10.5483/bmbrep.2008.41.10.722. PMID: 18959819.